8 septiembre 2014
Chronic obstructive pulmonary disease is associated with eosinophilic airway inflammation in 10–20 percent of patients. Benralizumab, a monoclonal antibody, has been shown to decrease the number of blood and sputum eosinophils.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/ExInxKEyFSI/140908083752.htm
